Bonteque Consulting
Develops cytisinicline and generic medicines for patients and healthcare markets
Highlights
- New on EvolcAdded 2026-11-14
About Bonteque Consulting
Bonteque Consulting develops cytisinicline, a medicine intended to help address nicotine addiction. It also invests in generic medicinal products and conducts research and development.
The company is registered in London, United Kingdom, and was founded in 2018. Its website provides adverse-event reporting information for medicinal products.
Product: Cytisinicline and generic medicinal products, supported by research and development.
Jobs at Bonteque Consulting
More biotech & pharma companies
Bounce Biomedical
Develops regenerative implants for patients with cartilage and bone injuries in jointsBowmed Ibisqus
Supplies generic injectable medicines to NHS hospitals and private healthcare providers in the UKBridge Farm Bioscience
Develops and manufactures plant-derived ingredients and extracts for pharmaceutical, nutraceutical and personal care businessesBright Biotech
Plant-based recombinant protein production for cell culture and regenerative medicine companiesNew on EvolcBroughton Laboratories
Analytical testing, scientific consultancy and regulatory support for life sciences and regulated product companiesNew on EvolcBS Animal Health
Official UK retailer of Vetiness dog and cat animal health products, including the EnteroFit digestive care lineYoung companyNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
No confirmed website technologies in the latest recorded checks.
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.